J&J vaccine pause seems like a 'perfectly reasonable approach' for U.S., professor says

Professor Neil Mabbott, chair of Immunopathology at the University of Edinburgh, discusses the U.S. decision to pause distribution of the Johnson & Johnson vaccine in order to investigate rare reports of blood clotting.